High-throughput cytotoxicity and antigen-binding assay for screening small bispecific antibodies without purification
The cytotoxicity of T cell-recruiting antibodies with their potential to damage late-stage tumor masses is critically dependent on their structural and functional properties. Recently, we reported a semi-high-throughput process for screening highly cytotoxic small bispecific antibodies (i.e., diabod...
Gespeichert in:
Veröffentlicht in: | Journal of bioscience and bioengineering 2018-08, Vol.126 (2), p.153-161 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 161 |
---|---|
container_issue | 2 |
container_start_page | 153 |
container_title | Journal of bioscience and bioengineering |
container_volume | 126 |
creator | Sugiyama, Aruto Umetsu, Mitsuo Nakazawa, Hikaru Niide, Teppei Asano, Ryutaro Hattori, Takamitsu Kumagai, Izumi |
description | The cytotoxicity of T cell-recruiting antibodies with their potential to damage late-stage tumor masses is critically dependent on their structural and functional properties. Recently, we reported a semi-high-throughput process for screening highly cytotoxic small bispecific antibodies (i.e., diabodies). In the present study, we improved the high-throughput performance of this screening process by removing the protein purification stage and adding a stage for determining the concentrations of the diabodies in culture supernatant. The diabodies were constructed by using an Escherichia coli expression system, and each diabody contained tandemly arranged peptide tags at the C-terminus, which allowed the concentration of diabodies in the culture supernatant to be quantified by using a tag-sandwich enzyme-linked immunosorbent assay. When estimated diabody concentrations were used to determine the cytotoxicity of unpurified antibodies, results comparable to those of purified antibodies were obtained. In a surface plasmon resonance spectroscopy-based target-binding assay, contaminants in the culture supernatant prevented us from conducting a quantitative binding analysis; however, this approach did allow relative binding affinity to be determined, and the relative binding affinities of the unpurified diabodies were comparable to those of the purified antibodies. Thus, we present here an improved high-throughput process for the simultaneous screening and determination of the binding parameters of highly cytotoxic bispecific antibodies.
[Display omitted]
•High-throughput process for screening highly cytotoxic bispecific antibodies was conducted without purification stage.•Tag-sandwich ELISA with tandemly-arranged peptide tags enabled to determine the recombinant antibodies in crude condition.•Surface plasmon resonance approach with the tag-sandwich ELISA supplied qualitative binding affinity from crude samples. |
doi_str_mv | 10.1016/j.jbiosc.2018.02.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2014956034</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1389172317312379</els_id><sourcerecordid>2014956034</sourcerecordid><originalsourceid>FETCH-LOGICAL-c516t-516af12fdc742c30e66e3c6771ddd2faf781f20f1998a1fdfe43ec6dfe7dffa03</originalsourceid><addsrcrecordid>eNp9kE9v3CAQxVGUKpuk-QZR5WMudgGzxr5UqqL8k1bqpT0jDMPurLzGBdx2v31wNu2xB5gRvPdG8yPkltGKUdZ83lf7Hn00FaesrSivKJVn5JLVQpZCcHa-9G1XMsnrFbmKcU8pk1SyC7Li3Vq0rRCXZH7G7a5Mu-Dn7W6aU2GOySf_Bw2mY6FHm0_CLYxlj6PFcVvoGPWxcD4U0QSAcXmLBz0MRY9xAoMOzZup9xYhFr8x7XwOnuawfOmEfvxIPjg9RLh5r9fkx-PD9_vncvPt6eX-66Y0a9akMl_aMe6skYKbmkLTQG0aKZm1ljvtZMscp451XauZsw5EDabJVVrnNK2vyd0pdwr-5wwxqQNGA8OgR_BzVBmd6NYNrUWWipPUBB9jAKemgAcdjopRtQBXe3UCvrhaRbnKwLPt0_uEuT-A_Wf6SzgLvpwEkPf8hRBUNAijAYsBTFLW4_8nvAJ46JgG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2014956034</pqid></control><display><type>article</type><title>High-throughput cytotoxicity and antigen-binding assay for screening small bispecific antibodies without purification</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Sugiyama, Aruto ; Umetsu, Mitsuo ; Nakazawa, Hikaru ; Niide, Teppei ; Asano, Ryutaro ; Hattori, Takamitsu ; Kumagai, Izumi</creator><creatorcontrib>Sugiyama, Aruto ; Umetsu, Mitsuo ; Nakazawa, Hikaru ; Niide, Teppei ; Asano, Ryutaro ; Hattori, Takamitsu ; Kumagai, Izumi</creatorcontrib><description>The cytotoxicity of T cell-recruiting antibodies with their potential to damage late-stage tumor masses is critically dependent on their structural and functional properties. Recently, we reported a semi-high-throughput process for screening highly cytotoxic small bispecific antibodies (i.e., diabodies). In the present study, we improved the high-throughput performance of this screening process by removing the protein purification stage and adding a stage for determining the concentrations of the diabodies in culture supernatant. The diabodies were constructed by using an Escherichia coli expression system, and each diabody contained tandemly arranged peptide tags at the C-terminus, which allowed the concentration of diabodies in the culture supernatant to be quantified by using a tag-sandwich enzyme-linked immunosorbent assay. When estimated diabody concentrations were used to determine the cytotoxicity of unpurified antibodies, results comparable to those of purified antibodies were obtained. In a surface plasmon resonance spectroscopy-based target-binding assay, contaminants in the culture supernatant prevented us from conducting a quantitative binding analysis; however, this approach did allow relative binding affinity to be determined, and the relative binding affinities of the unpurified diabodies were comparable to those of the purified antibodies. Thus, we present here an improved high-throughput process for the simultaneous screening and determination of the binding parameters of highly cytotoxic bispecific antibodies.
[Display omitted]
•High-throughput process for screening highly cytotoxic bispecific antibodies was conducted without purification stage.•Tag-sandwich ELISA with tandemly-arranged peptide tags enabled to determine the recombinant antibodies in crude condition.•Surface plasmon resonance approach with the tag-sandwich ELISA supplied qualitative binding affinity from crude samples.</description><identifier>ISSN: 1389-1723</identifier><identifier>EISSN: 1347-4421</identifier><identifier>DOI: 10.1016/j.jbiosc.2018.02.007</identifier><identifier>PMID: 29548844</identifier><language>eng</language><publisher>Japan: Elsevier B.V</publisher><subject>Antibodies, Bispecific - chemistry ; Antibodies, Bispecific - metabolism ; Antibodies, Bispecific - pharmacology ; Antibody-Dependent Cell Cytotoxicity - physiology ; Binding affinity screening ; Cancer Vaccines - analysis ; Cancer Vaccines - metabolism ; Cancer therapy ; Cytotoxicity screening ; Cytotoxicity Tests, Immunologic - methods ; Enzyme-Linked Immunosorbent Assay - methods ; High-throughput screening ; High-Throughput Screening Assays - methods ; Humans ; Immunotherapy ; Sandwich ELISA ; T-cell recruiting antibody ; Tumor Cells, Cultured</subject><ispartof>Journal of bioscience and bioengineering, 2018-08, Vol.126 (2), p.153-161</ispartof><rights>2018 The Society for Biotechnology, Japan</rights><rights>Copyright © 2018 The Society for Biotechnology, Japan. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c516t-516af12fdc742c30e66e3c6771ddd2faf781f20f1998a1fdfe43ec6dfe7dffa03</citedby><cites>FETCH-LOGICAL-c516t-516af12fdc742c30e66e3c6771ddd2faf781f20f1998a1fdfe43ec6dfe7dffa03</cites><orcidid>0000-0001-6795-8377</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jbiosc.2018.02.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29548844$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sugiyama, Aruto</creatorcontrib><creatorcontrib>Umetsu, Mitsuo</creatorcontrib><creatorcontrib>Nakazawa, Hikaru</creatorcontrib><creatorcontrib>Niide, Teppei</creatorcontrib><creatorcontrib>Asano, Ryutaro</creatorcontrib><creatorcontrib>Hattori, Takamitsu</creatorcontrib><creatorcontrib>Kumagai, Izumi</creatorcontrib><title>High-throughput cytotoxicity and antigen-binding assay for screening small bispecific antibodies without purification</title><title>Journal of bioscience and bioengineering</title><addtitle>J Biosci Bioeng</addtitle><description>The cytotoxicity of T cell-recruiting antibodies with their potential to damage late-stage tumor masses is critically dependent on their structural and functional properties. Recently, we reported a semi-high-throughput process for screening highly cytotoxic small bispecific antibodies (i.e., diabodies). In the present study, we improved the high-throughput performance of this screening process by removing the protein purification stage and adding a stage for determining the concentrations of the diabodies in culture supernatant. The diabodies were constructed by using an Escherichia coli expression system, and each diabody contained tandemly arranged peptide tags at the C-terminus, which allowed the concentration of diabodies in the culture supernatant to be quantified by using a tag-sandwich enzyme-linked immunosorbent assay. When estimated diabody concentrations were used to determine the cytotoxicity of unpurified antibodies, results comparable to those of purified antibodies were obtained. In a surface plasmon resonance spectroscopy-based target-binding assay, contaminants in the culture supernatant prevented us from conducting a quantitative binding analysis; however, this approach did allow relative binding affinity to be determined, and the relative binding affinities of the unpurified diabodies were comparable to those of the purified antibodies. Thus, we present here an improved high-throughput process for the simultaneous screening and determination of the binding parameters of highly cytotoxic bispecific antibodies.
[Display omitted]
•High-throughput process for screening highly cytotoxic bispecific antibodies was conducted without purification stage.•Tag-sandwich ELISA with tandemly-arranged peptide tags enabled to determine the recombinant antibodies in crude condition.•Surface plasmon resonance approach with the tag-sandwich ELISA supplied qualitative binding affinity from crude samples.</description><subject>Antibodies, Bispecific - chemistry</subject><subject>Antibodies, Bispecific - metabolism</subject><subject>Antibodies, Bispecific - pharmacology</subject><subject>Antibody-Dependent Cell Cytotoxicity - physiology</subject><subject>Binding affinity screening</subject><subject>Cancer Vaccines - analysis</subject><subject>Cancer Vaccines - metabolism</subject><subject>Cancer therapy</subject><subject>Cytotoxicity screening</subject><subject>Cytotoxicity Tests, Immunologic - methods</subject><subject>Enzyme-Linked Immunosorbent Assay - methods</subject><subject>High-throughput screening</subject><subject>High-Throughput Screening Assays - methods</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Sandwich ELISA</subject><subject>T-cell recruiting antibody</subject><subject>Tumor Cells, Cultured</subject><issn>1389-1723</issn><issn>1347-4421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9v3CAQxVGUKpuk-QZR5WMudgGzxr5UqqL8k1bqpT0jDMPurLzGBdx2v31wNu2xB5gRvPdG8yPkltGKUdZ83lf7Hn00FaesrSivKJVn5JLVQpZCcHa-9G1XMsnrFbmKcU8pk1SyC7Li3Vq0rRCXZH7G7a5Mu-Dn7W6aU2GOySf_Bw2mY6FHm0_CLYxlj6PFcVvoGPWxcD4U0QSAcXmLBz0MRY9xAoMOzZup9xYhFr8x7XwOnuawfOmEfvxIPjg9RLh5r9fkx-PD9_vncvPt6eX-66Y0a9akMl_aMe6skYKbmkLTQG0aKZm1ljvtZMscp451XauZsw5EDabJVVrnNK2vyd0pdwr-5wwxqQNGA8OgR_BzVBmd6NYNrUWWipPUBB9jAKemgAcdjopRtQBXe3UCvrhaRbnKwLPt0_uEuT-A_Wf6SzgLvpwEkPf8hRBUNAijAYsBTFLW4_8nvAJ46JgG</recordid><startdate>20180801</startdate><enddate>20180801</enddate><creator>Sugiyama, Aruto</creator><creator>Umetsu, Mitsuo</creator><creator>Nakazawa, Hikaru</creator><creator>Niide, Teppei</creator><creator>Asano, Ryutaro</creator><creator>Hattori, Takamitsu</creator><creator>Kumagai, Izumi</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6795-8377</orcidid></search><sort><creationdate>20180801</creationdate><title>High-throughput cytotoxicity and antigen-binding assay for screening small bispecific antibodies without purification</title><author>Sugiyama, Aruto ; Umetsu, Mitsuo ; Nakazawa, Hikaru ; Niide, Teppei ; Asano, Ryutaro ; Hattori, Takamitsu ; Kumagai, Izumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c516t-516af12fdc742c30e66e3c6771ddd2faf781f20f1998a1fdfe43ec6dfe7dffa03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antibodies, Bispecific - chemistry</topic><topic>Antibodies, Bispecific - metabolism</topic><topic>Antibodies, Bispecific - pharmacology</topic><topic>Antibody-Dependent Cell Cytotoxicity - physiology</topic><topic>Binding affinity screening</topic><topic>Cancer Vaccines - analysis</topic><topic>Cancer Vaccines - metabolism</topic><topic>Cancer therapy</topic><topic>Cytotoxicity screening</topic><topic>Cytotoxicity Tests, Immunologic - methods</topic><topic>Enzyme-Linked Immunosorbent Assay - methods</topic><topic>High-throughput screening</topic><topic>High-Throughput Screening Assays - methods</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Sandwich ELISA</topic><topic>T-cell recruiting antibody</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sugiyama, Aruto</creatorcontrib><creatorcontrib>Umetsu, Mitsuo</creatorcontrib><creatorcontrib>Nakazawa, Hikaru</creatorcontrib><creatorcontrib>Niide, Teppei</creatorcontrib><creatorcontrib>Asano, Ryutaro</creatorcontrib><creatorcontrib>Hattori, Takamitsu</creatorcontrib><creatorcontrib>Kumagai, Izumi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of bioscience and bioengineering</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sugiyama, Aruto</au><au>Umetsu, Mitsuo</au><au>Nakazawa, Hikaru</au><au>Niide, Teppei</au><au>Asano, Ryutaro</au><au>Hattori, Takamitsu</au><au>Kumagai, Izumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High-throughput cytotoxicity and antigen-binding assay for screening small bispecific antibodies without purification</atitle><jtitle>Journal of bioscience and bioengineering</jtitle><addtitle>J Biosci Bioeng</addtitle><date>2018-08-01</date><risdate>2018</risdate><volume>126</volume><issue>2</issue><spage>153</spage><epage>161</epage><pages>153-161</pages><issn>1389-1723</issn><eissn>1347-4421</eissn><abstract>The cytotoxicity of T cell-recruiting antibodies with their potential to damage late-stage tumor masses is critically dependent on their structural and functional properties. Recently, we reported a semi-high-throughput process for screening highly cytotoxic small bispecific antibodies (i.e., diabodies). In the present study, we improved the high-throughput performance of this screening process by removing the protein purification stage and adding a stage for determining the concentrations of the diabodies in culture supernatant. The diabodies were constructed by using an Escherichia coli expression system, and each diabody contained tandemly arranged peptide tags at the C-terminus, which allowed the concentration of diabodies in the culture supernatant to be quantified by using a tag-sandwich enzyme-linked immunosorbent assay. When estimated diabody concentrations were used to determine the cytotoxicity of unpurified antibodies, results comparable to those of purified antibodies were obtained. In a surface plasmon resonance spectroscopy-based target-binding assay, contaminants in the culture supernatant prevented us from conducting a quantitative binding analysis; however, this approach did allow relative binding affinity to be determined, and the relative binding affinities of the unpurified diabodies were comparable to those of the purified antibodies. Thus, we present here an improved high-throughput process for the simultaneous screening and determination of the binding parameters of highly cytotoxic bispecific antibodies.
[Display omitted]
•High-throughput process for screening highly cytotoxic bispecific antibodies was conducted without purification stage.•Tag-sandwich ELISA with tandemly-arranged peptide tags enabled to determine the recombinant antibodies in crude condition.•Surface plasmon resonance approach with the tag-sandwich ELISA supplied qualitative binding affinity from crude samples.</abstract><cop>Japan</cop><pub>Elsevier B.V</pub><pmid>29548844</pmid><doi>10.1016/j.jbiosc.2018.02.007</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-6795-8377</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1389-1723 |
ispartof | Journal of bioscience and bioengineering, 2018-08, Vol.126 (2), p.153-161 |
issn | 1389-1723 1347-4421 |
language | eng |
recordid | cdi_proquest_miscellaneous_2014956034 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Antibodies, Bispecific - chemistry Antibodies, Bispecific - metabolism Antibodies, Bispecific - pharmacology Antibody-Dependent Cell Cytotoxicity - physiology Binding affinity screening Cancer Vaccines - analysis Cancer Vaccines - metabolism Cancer therapy Cytotoxicity screening Cytotoxicity Tests, Immunologic - methods Enzyme-Linked Immunosorbent Assay - methods High-throughput screening High-Throughput Screening Assays - methods Humans Immunotherapy Sandwich ELISA T-cell recruiting antibody Tumor Cells, Cultured |
title | High-throughput cytotoxicity and antigen-binding assay for screening small bispecific antibodies without purification |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T19%3A47%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High-throughput%20cytotoxicity%20and%20antigen-binding%20assay%20for%20screening%20small%20bispecific%20antibodies%20without%20purification&rft.jtitle=Journal%20of%20bioscience%20and%20bioengineering&rft.au=Sugiyama,%20Aruto&rft.date=2018-08-01&rft.volume=126&rft.issue=2&rft.spage=153&rft.epage=161&rft.pages=153-161&rft.issn=1389-1723&rft.eissn=1347-4421&rft_id=info:doi/10.1016/j.jbiosc.2018.02.007&rft_dat=%3Cproquest_cross%3E2014956034%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2014956034&rft_id=info:pmid/29548844&rft_els_id=S1389172317312379&rfr_iscdi=true |